Key Market Indicators
Kazakhstan is projected to achieve a vaccination coverage of 99% for children aged one by 2028, up from 98% in 2023. This represents an average annual growth of 0.2 percentage points. The vaccination rate has remained stable since 1997. In contrast, Kazakhstan's vaccine export market is expected to decline dramatically. By 2028, vaccine exports are forecasted to plummet to approximately $280, down from $12,000 in 2023. This represents an average annual decrease of 50.7%. The country's vaccine supply has been dwindling since 2009, with an average annual decline of 13.6%. In 2023, Kazakhstan ranked 53rd in vaccine exports, with Brunei surpassing it at $12,000. Leading the global rankings are Belgium, the United Kingdom, and France. On the import front, Kazakhstan's vaccine imports are set to rise. By 2028, imports are expected to reach around $135 million, up from $115 million in 2023. This marks an average annual growth rate of 2.3%. Since 2006, the country's demand for imported vaccines has increased by 5.4% annually.
